During the past decade, Herlev Hospital; Afdeling for Kræftbehandling conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herlev Hospital; Afdeling for Kræftbehandling" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Herlev Hospital; Afdeling for Kræftbehandling" are "Breast Cancer" (5 trials), "Renal Cell Carcinoma" (3 trials), "Solid Tumors" (3 trials), "Ovarian Cancer" (2 trials) and "Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Herlev Hospital; Afdeling for Kræftbehandling" in a lesser frequency.

Most popular intervention types in "Herlev Hospital; Afdeling for Kræftbehandling" are "Drug" (25 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (11 trials), "Paclitaxel" (5 trials), "Placebo" (5 trials), "Bevacizumab" (4 trials) and "Pertuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Herlev Hospital; Afdeling for Kræftbehandling" are 22 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Herlev Hospital; Afdeling for Kræftbehandling". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Herlev Hospital; Afdeling for Kræftbehandling, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Herlev Hospital; Afdeling for Kræftbehandling, 5 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".